Abstract
AbstractThe phenotypic plasticity of cancer cells has recently emerged as an important factor of treatment failure. The mechanisms of phenotypic plasticity are not fully understood. One of the hypotheses is that the degree of chromatin accessibility defines the easiness of cell transitions between different phenotypes. To test this, a method to compare overall chromatin accessibility between cells in a population or between cell populations is needed. We propose to measure chromatin accessibility by fluorescence signal from nuclei of cells stained with DNA binding fluorescent molecules. This method is based on the observations that small molecules bind nucleosome-free DNA more easily than nucleosomal DNA. Thus, nuclear fluorescence is proportional to the amount of nucleosome-free DNA, serving as a measure of chromatin accessibility. We optimized the method using several DNA intercalators and minor groove binders and known chromatin-modulating agents and demonstrated that chromatin accessibility is increased upon oncogene-induced transformation and further in tumor cells.
Publisher
Cold Spring Harbor Laboratory
Reference27 articles.
1. Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
2. Minnoye L , Marinov GK , Krausgruber T , Pan L , Marand AP , Secchia S et al. Chromatin accessibility profiling methods. Nat Rev Methods Primers 2021; 1.
3. The Overlooked Fact: Fundamental Need for Spike-In Control for Virtually All Genome-Wide Analyses;Mol Cell Biol,2015
4. Chereji RV , Bryson TD , Henikoff S . Quantitative MNase-seq accurately maps nucleosome occupancy levels. Genome Biol 2019; 20: 198.
5. Flow cytometric evaluation of DNA stainability with propidium iodide after histone H1 extraction